Malaria Research Today is a free monthly online journal that collates and summarizes the latest research about Malaria, including details on prevention, treatment, causes, mosquitoes.

Volume 4 (2007), Issue 4 (April)

1. Multiple sclerosis and anti-Plasmodium falciparum innate immune response.
   J Neuroimmunol, 185(1): 201-7. [Abstract] [Full-text]
2. Artesunate, artemether or quinine in severe Plasmodium falciparum malaria?
   Expert Rev Anti Infect Ther, 5(2): 199-204. [Abstract] [Full-text]
3. Large-scale malaria survey in Cambodia: novel insights on species distribution and risk factors.
   Malar J, 6: 37. [Abstract] [Full-text]
4. Spectrin-based skeleton in red blood cells and malaria.
   Curr Opin Hematol, 14(3): 198-202. [Abstract] [Full-text]
5. Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.
   Clin Vaccine Immunol, 14(4): 342-7. [Abstract] [Full-text]
6. Diagnosis and treatment of malaria in peripheral health facilities in Uganda: findings from an area of low transmission in south-western Uganda.
   Malar J, 6: 39. [Abstract] [Full-text]
7. The pathology of Plasmodium chabaudi infection is not ameliorated by the secreted filarial nematode immunomodulatory molecule, ES-62.
   Parasite Immunol, 29(5): 271-6. [Abstract] [Full-text]
8. Significant differences in GM allotype frequencies between two sympatric tribes with markedly differential susceptibility to malaria.
   Parasite Immunol, 29(5): 267-9. [Abstract] [Full-text]
9. Can fungal biopesticides control malaria?
   Nat Rev Microbiol, 5(5): 377-83. [Abstract] [Full-text]
10. Acute acalculous cholecystitis in a child returning from the Ivory Coast.
    Pediatr Emerg Care, 23(4): 242-3. [Abstract] [Full-text]
11. Malaria vaccine efficacy: the difficulty of detecting and diagnosing malaria.
    Malar J, 6: 36. [Abstract] [Full-text]
12. Assessing developmental outcomes in children from Kilifi, Kenya, following prophylaxis for seizures in cerebral malaria.
    J Health Psychol, 12(3): 417-30. [Abstract] [Full-text]
13. Electronic mosquito repellents for preventing mosquito bites and malaria infection.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
14. Uninfected mosquito bites confer protection against infection with malaria parasites.
    Infect Immun, 75(5): 2523-30. [Abstract] [Full-text]
15. Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone.
    Infect Immun, 75(5): 2283-90. [Abstract] [Full-text]
16. Primary infection of C57BL/6 mice with Plasmodium yoelii induces a heterogeneous response of NKT cells.
    Infect Immun, 75(5): 2511-22. [Abstract] [Full-text]
17. Immunoglobulin G antibody reactivity to a group A Plasmodium falciparum erythrocyte membrane protein 1 and protection from P. falciparum malaria.
    Infect Immun, 75(5): 2415-20. [Abstract] [Full-text]
18. Submicroscopic Plasmodium falciparum gametocyte carriage is common in an area of low and seasonal transmission in Tanzania.
    Trop Med Int Health, 12(4): 547-53. [Abstract] [Full-text]
19. Diagnosis and management of malaria by rural community health providers in the Lao People's Democratic Republic (Laos).
    Trop Med Int Health, 12(4): 540-6. [Abstract] [Full-text]
20. Intermittent preventive treatment of malaria in pregnancy: the effect of new delivery approaches on access and compliance rates in Uganda.
    Trop Med Int Health, 12(4): 519-31. [Abstract] [Full-text]
21. Malaria deaths as sentinel events to monitor healthcare delivery and antimalarial drug safety.
    Trop Med Int Health, 12(5): 617-28. [Abstract] [Full-text]
22. Delayed cord clamping and haemoglobin levels in infancy: a randomised controlled trial in term babies.
    Trop Med Int Health, 12(5): 603-16. [Abstract] [Full-text]
23. The antigenicity of a Plasmodium vivax reticulocyte binding protein-1 (PvRBP1) recombinant fragment in humans and its immunogenicity and protection studies in Aotus monkeys.
    Vaccine, 25(18): 3713-21. [Abstract] [Full-text]
24. Imported malaria in children: a review of clinical studies.
    Lancet Infect Dis, 7(5): 349-57. [Abstract] [Full-text]
25. Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria.
    Antimicrob Agents Chemother, 51(5): 1869-71. [Abstract] [Full-text]
26. Activities of amodiaquine, artesunate, and artesunate-amodiaquine against asexual- and sexual-stage parasites in falciparum malaria in children.
    Antimicrob Agents Chemother, 51(5): 1694-9. [Abstract] [Full-text]
27. Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay.
    Malar J, 6: 44. [Abstract] [Full-text]
28. Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.
    Malar J, 6: 41. [Abstract] [Full-text]
29. Murine cerebral malaria development is independent of toll-like receptor signaling.
    Am J Pathol, 170(5): 1640-8. [Abstract] [Full-text]
30. Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria.
    Proc Natl Acad Sci U S A, 104(17): 7169-74. [Abstract] [Full-text]
31. Aldolase provides an unusual binding site for thrombospondin-related anonymous protein in the invasion machinery of the malaria parasite.
    Proc Natl Acad Sci U S A, 104(17): 7015-20. [Abstract] [Full-text]
32. Choice of treatment for fever at household level in Malawi: examining spatial patterns.
    Malar J, 6: 40. [Abstract] [Full-text]
33. Congenital malaria with atypical presentation: a case report from low transmission area in India.
    Malar J, 6: 43. [Abstract] [Full-text]
34. Severe sepsis due to severe falciparum malaria and leptospirosis co-infection treated with activated protein C.
    Malar J, 6: 42. [Abstract] [Full-text]
35. Viral vector vaccines make memory T cells against malaria.
    Immunology, 121(2): 158-65. [Abstract] [Full-text]
36. Tafenoquine: a promising new antimalarial agent.
    Expert Opin Investig Drugs, 16(5): 705-15. [Abstract] [Full-text]
37. Micro-epidemiology of Plasmodium falciparum malaria: Is there any difference in transmission risk between neighbouring villages?
    Malar J, 6: 46. [Abstract] [Full-text]

© 2004-2008 Malaria Research Today. All Rights Reserved.